Dr. Goodenowe publishes research on the relationship between plasmalogens and the APOE e4 genotype

Dr. Goodenowe’s latest peer-reviewed published research shows that a person’s levels of plasmalogens, a critical lipid molecule required for brain and nerve function, is a better indicator of risk of Alzheimer’s disease than the established genetic risk factor APOE e4. This research further emphasizes the need for a plasmalogen blood test to assess risk of Alzheimer’s disease …

Dr. Goodenowe publishes research on the relationship between plasmalogens and the APOE e4 genotype Read More »